cladribine

This page shows the latest cladribine news and features for those working in and with pharma, biotech and healthcare.

MS and cholesterol drugs picked for new UK rapid uptake push

Merck’s Mavenclad (cladribine) for treating highly active relapsing-remitting multiple sclerosis in adults - A drug for multiple sclerosis with a novel mode of action, high efficacy and a low treatment

Latest news

Sanofi licences Principia MS drug in $805m deal

The three established players in the oral MS therapy category are also about to see additional competition from new entrant Merck KGaA, which bagged EU approval for Mavenclad (cladribine) in August.
Merck mulls sale of consumer health division

The news comes a few days after Merck picked up an important new approval for its pharma division in Europe, with the EMA clearing Mavenclad (cladribine) for the treatment of
Merck gets CHMP backing for long-delayed oral MS drug

Follow-up studies also revealed that oral cladribine could be stopped in year three and four without an increase in relapses. ... The company thinks oral cladribine has a key differentiator from its rivals, which require daily dosing.
Avelumab costs peg back profit at Merck KGaA

Avelumab and other pipeline candidates such as oral MS therapy cladribine have assumed even more importance for Merck since it abandoned plans to seek approval of evofosfamide in advanced soft tissue
Merck's pharma unit faces tougher 2017 as fertility boost recedes

Top of that list is oral MS therapy cladribine, which was submitted for approval in the EU in June, and according to Kuhnert is proceeding through regulatory review as expected.

More from news
Approximately 2 fully matching, plus 26 partially matching documents found.

Latest appointments

XenoPort appoints chief medical officer

Prior to joining Biogen Idec Dr Kim was with Merck Serono, serving as medical director for the phase III programme of cladribine, which failed to impress in MS.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Consultant Health Economics - London / Oxford: Negotiable

Healthcare Communications Account Directors x 2: Salary TBC

Healthcare Advertising Senior Account Manager / AD / Senior AD: Salary TBC

Account Manager / Account Director: Competative

Account Director: £48, 000 - £60, 000

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Medical Writers: Competitive Salary and Benefits

Associate Medical Director: Highly Competitive

Principal Health Economist - North-West: Negotiable

Senior Medical Writer (Remote Working): Competitive Salary Offered

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Associate Medical Director: Excellent PTO, bonus and 401k package

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Executive, London, Medical Communications: Excellent package

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

New Business Director - PR: Competitive Salary and benefits

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Project / Account Manager (Medical Education): Salary TBC

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Subscribe to our email news alerts

PMHub

Add my company

SEVEN STONES

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

A reflection of ESMO: Client Relationship Director Fabienne Wild from Ashfield Meetings & Events reflects on the recent conference season and on her experience at the European Society for Medical Oncology (ESMO)....
OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....